Myasthenia Gravis Clinical Trials
Sutter Health participates in clinical trials related to Myasthenia Gravis throughout their Northern California facilities. See the listing below for an overview of current trials, including contact information. For some trials, more detailed information can be found via the title link to ClinicalTrials.gov.
Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG) Opens in a new window
Description: The purpose of this study is to determine if eculizumab is safe and effective for the treatment of patients with refractory gMG..
Investigator: Jonathan Katz, MD
Eligibility: Subjects with generalized myasthenia gravis (gMG) who have needed at least two immunosuppressive drugs, or one immunosuppressive drug and regular plasma exchange or IVIG to control symptoms.
Status: Active and open to enrollment
Location: California Pacific Medical Center
Contact: Marguerite Engle, 415-600-3758, Email: EngleM@cpmcri.org
> See All Neurology Clinical Trials by Condition